期刊文献+

Reduced semen quality in patients with testicular cancer seminoma is associated with alterations in the expression of sperm proteins 被引量:1

原文传递
导出
摘要 Testicular cancer seminoma is one of the most common types of cancer among men of reproductive age.Patients with this condition usually present reduced semen quality,even before initiating cancer therapy.However,the underlying mechanisms by which testicular cancer seminoma affects male fertility are largely unknown.The aim of this study was to investigate alterations in the sperm proteome of men with seminoma undergoing sperm banking before starting cancer therapy,in comparison to healthy proven fertile men(control group).A routine semen analysis was conducted before cryopreservation of the samples(n=15 per group).Men with seminoma showed a decrease in sperm motility(P=0.019),total motile count(P=0.001),concentration(P=0.003),and total sperm count(P=0.001).Quantitative proteomic analysis identified 393 differentially expressed proteins between the study groups.Ten proteins involved in spermatogenesis,sperm function,binding of sperm to the oocyte,and fertilization were selected for validation by western blot.We confirmed the underexpression of heat shock-related 70 kDa protein 2(P=0.041),ubiquinol-cytochrome C reductase core protein 2(P=0.026),and testis-specific sodium/potassium-transporting ATPase subunit alpha-4(P=0.016),as well as the overexpression of angiotensin I converting enzyme(P=0.005)in the seminoma group.The altered expression levels of these proteins are associated with spermatogenesis dysfunction,reduced sperm kinematics and motility,failure in capacitation and fertilization.The findings of this study may explain the decrease in the fertilizing ability of men with seminoma before starting cancer therapy.
出处 《Asian Journal of Andrology》 SCIE CAS CSCD 2020年第1期88-93,共6页 亚洲男性学杂志(英文版)
基金 Financial support for this study was provided by the American Center for Reproductive Medicine,Cleveland Clinic,OH,USA Tania R Dias was supported by the Portuguese Foundation for Science and Technology(FCT,SFRH/BD/109284/2015) Fulbright Program(E0585639).
  • 相关文献

参考文献2

二级参考文献114

  • 1McGlynn KA, Devesa SS, Sigurdson A J, Brown LM, Tsao L, etal. Trends in the incidence of testicular germ cell tumors in the United States. Cancer 2003, 91: 63-70.
  • 2Schagen SB, Boogerd W, Muller M J, Huinink WT, Moonen L, et al. Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer. Acta Onco12008, 47: 63-70.
  • 3Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, et al. EUROCARE-4 Working Group. Recent cancer survival in Europ: a 2000-02 period analysis of EUROCARE-4 data. Lancet Onco12007, 8: 784-96.
  • 4Shetty G, Meistrich ML. Hormonal approaches to preservation and restoration of male fertility after cancer treatment. J Natl Cancer Inst Monogr 2005, 33: 36-9.
  • 5Huyghe E, Matsuda T, Daudin M, Chevreau C, Bachaud JM, et al. Fertility after testicular cancer treatments: results of a large multicenter study. Cancer 2004, 100: 732-7.
  • 6Kim C, McGlynn KA, McCorkle R, Zheng T, Erickson RL, etal. Fertility among testicular cancer survivors: a case-control study in the U.S:/CancerSurviv2010, 4: 266-73.
  • 7Fraietta R, Spaine DM, Bertolla RP, Ortiz V, Cedenho AP. Individual and seminal characteristics of patients with testicular germ cell tumors. Fertil Steri12010, 94: 2107-12.
  • 8O'Flaherty C, Hales BF, Chan P, Robaire B. Impact of chemotherapeutics and advanced testicular cancer or Hodgkin lymphoma on sperm deoxyribonucleic acid integrity. Fertil Steri12010, 94: 1374-9.
  • 9Brennemann W, StoffeI-Wagner B, Helmers A, Mezger 3, Joger N, et al. Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer. J Uro11997, 158: 844-50.
  • 10Magelssen H, Brydoy M, FossA SD. The effects of cancer and cancer treatments on ma e reproduct ve funct on. Nat Clin Pract Uro12006, 3: 312-22.

共引文献9

同被引文献1

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部